Autopsy report · NCT00387101

Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers

“Low recruitment rate”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months after it had already started.
• Ran for about 2 years 2 months before it stopped.
• 288 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

ApoPharma

Sponsor type

Industry

Conditions

Diabetic Foot Ulcer

Interventions

Dermal - Living Skin Replacement (Dermal - LSR)

Participants

288 (planned, not actual)

Sites

12

Countries

United States

Trials that died the same way

• NHFOV Versus NCPAP to Prevent Exubation Failure
  “Poor recruitment rate” (95% match in meaning)
• Prospective Randomized Controlled Trial of Obstructed Defecation Surgery
  “Due to low recruitment rate” (90% match in meaning)
• Management of Angiotensin Inhibitors During the Perioperative Period
  “slow recruitment rate” (89% match in meaning)
• Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients
  “Low recruitment” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.